Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
Free White Paper
As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
China Resources Pharma Files for $1 Billion IPO in Hong Kong | June 29, 2016
Pfizer Breaks Ground on $350 Million Biosimilar Plant in China | June 28, 2016
Jiangsu Hengrui Leads $100 Million Investment in US Spin-Off | June 24, 2016
Gan & Lee Plans $226 Million China IPO | June 16, 2016>> See all top stories...
ChinaBio® in the News